Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes

Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes

The quantity of programmed cell death-ligand 1 (PD-L1) is regarded as a predicting factor of clinical response to anti-PD-1 axis immunotherapy. However, the expression of PD-L1 and its prognostic value in hepatocellular carcinoma (HCC) patients remain debated. Meanwhile, the molecular features of PD...

Full description

Bibliographic Details
Main Authors:	Haotian Liao, Wen Chen, Yunlu Dai, Joseph J. Richardson, Junling Guo, Kefei Yuan, Yong Zeng, Kunlin Xie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-09-01
Series:	Frontiers in Oncology
Subjects:	programmed cell death-ligands macrophage tumor immune stroma tumor microenvironment anti-PD-1 axis therapy hepatocellular carcinoma
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.00883/full

Similar Items

Tumor–stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
by: Dong Wang, et al.
Published: (2023-05-01)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
by: Hsin-Lun Lee, et al.
Published: (2023-07-01)

OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis
by: Kunlin Xie, et al.
Published: (2018-04-01)

Tumor-Stroma Ratio and Programmed Cell Death Ligand 1 Expression in Preoperative Biopsy and Matched Laryngeal Carcinoma Surgical Specimen
by: Lara Alessandrini, et al.
Published: (2022-07-01)

Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
by: Dong-Jun Park, et al.
Published: (2021-04-01)

Macrophages and hepatocellular carcinoma
by: Zhiqiang Tian, et al.
Published: (2019-09-01)

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma
by: Jiankang Xiang, et al.
Published: (2023-03-01)

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
by: Natalie Silk, et al.
Published: (2021-02-01)

MicroRNA targeting to modulate tumor microenvironment
by: Praneeth R Kuninty, et al.
Published: (2016-01-01)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
by: Lucy V. Ireland, et al.
Published: (2018-10-01)

The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies
by: Giovanni Zarrilli, et al.
Published: (2020-10-01)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
by: Evangelos Koustas, et al.
Published: (2019-04-01)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
by: Maria Kotsari, et al.
Published: (2023-07-01)

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
by: Pil Soo Sung
Published: (2022-07-01)

The Role of Neural Signaling in the Pancreatic Cancer Microenvironment
by: Ryota Takahashi, et al.
Published: (2022-08-01)

Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment
by: Qingqing HANG, et al.
Published: (2020-10-01)

The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance
by: Olga M. Kutova, et al.
Published: (2023-01-01)

Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
by: Jingyi Zhou, et al.
Published: (2021-02-01)

Platelets as Key Factors in Hepatocellular Carcinoma
by: Natasa Pavlovic, et al.
Published: (2019-07-01)

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
by: Jiakang Jin, et al.
Published: (2021-07-01)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
by: Shohei Mukai, et al.
Published: (2021-11-01)

Remodeling of Tumor Stroma and Response to Therapy
by: Ruth Ganss, et al.
Published: (2012-03-01)

The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
by: Camilla Volponi, et al.
Published: (2022-12-01)

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment
by: Chunting Zeng, et al.
Published: (2022-06-01)

Tumor-Associated CD163+ M2 Macrophage Infiltration is Highly Associated with PD-L1 Expression in Cervical Cancer
by: Guo F, et al.
Published: (2020-07-01)

Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
by: Christina Mertens, et al.
Published: (2018-03-01)

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
by: Hari Menon, et al.
Published: (2019-02-01)

Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer
by: Kaitang Huang, et al.
Published: (2021-05-01)

The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
by: Xinyi Zhang, et al.
Published: (2023-12-01)

Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family
by: Linxin Teng, et al.
Published: (2022-12-01)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2021-02-01)

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma
by: Yuanfei Lu, et al.
Published: (2022-08-01)

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
by: Konstantinos Arvanitakis, et al.
Published: (2022-01-01)

Impact of the Stroma on the Biological Characteristics of the Parenchyma in Oral Squamous Cell Carcinoma
by: Kiyofumi Takabatake, et al.
Published: (2020-10-01)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
by: Luo M, et al.
Published: (2021-08-01)

Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1‐dependent tumor immunosuppressive microenvironment
by: Yuan Gao, et al.
Published: (2024-04-01)

Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance
by: Selma Maacha, et al.
Published: (2019-03-01)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01)

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
by: Jingquan Huang, et al.
Published: (2023-11-01)